Management of Male Breast Cancer
Key Points
Key Points
In 2019, an estimated 2,670 new cases of breast cancer will be diagnosed among men in the United States, and about 500 men will die from breast cancer.
The lifetime risk of breast cancer is about 1:1000 for a man, whereas it is approximately 1:8 for a woman.
There are substantial knowledge gaps concerning the optimal management of breast cancer in men.
To date, approaches to treating men with breast cancer have been extrapolated largely from research conducted in women with breast cancer.
Treatment
...reatment...
...ormone receptor-positive breast cancer wh...
...en with hormone receptor-positive bre...
...who are treated with adjuvant endocrine...
...o have completed five years of tamoxifen, have...
...n with early-stage breast cancer sho...
...advanced or metastatic, hormone receptor...
...op recurrent metastatic, hormone receptor-pos...
...crine therapy for men with advanced or metastatic,...
...therapy guided by HER2, PDL-1, PIK3C...
...nt of endocrine therapy toxicity is similar...
...sterone/androgen supplementation should...
...uld counsel patients about the symptoms of...
...nual mammogram should be offered to...
...alateral annual mammogram may be offered to men...
...ot recommended routinely in men with a...
...patients with breast cancer should be...
...tions That Did Not Reach the Required 75% Consen...